Results 161 to 170 of about 9,833 (206)

In silico and in vitro evaluation of the potential genotoxic impurities of vildagliptin. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Hamitoğlu M, Tugcu G, Kılıç AG, Esen G, Aydin A.   +4 more
europepmc   +1 more source

Can vildagliptin protect against radiation-induced premature ovarian failure? Insights into the AMPK and AKT signaling pathways. [PDF]

BMC Pharmacol Toxicol
Mahgoub NA, El-Sherbiny DA, El-Demerdash E.   +2 more
europepmc   +1 more source

Association of <i>DPP4</i> Gene Variants with Classic and DPP4 Inhibitor-Associated Bullous Pemphigoid. [PDF]

Int J Mol Sci
Achilla C, Foutsitzidou C, Meltzanidou P, Patsatsi A, Lazaridou E, Tzatzagou G, Lambropoulos A, Chatzikyriakidou A.   +7 more
europepmc   +1 more source

The antifibrotic effect of Vildagliptin and Diaminodiphenyl Sulfone in murine schistosomiasis mansoni. [PDF]

Sci Rep
Hendawy AS, Sabra AA, George MY, Rashad E, El-Demerdash E, Botros SS.   +5 more
europepmc   +1 more source

Comparative Effect of SGLT2 Inhibitors and GLP-1 Agonists on Glycemic Control in Type 2 Diabetes Mellitus.

J Pharm Bioallied Sci
Prakash V, Gupta S, Singh S, Rawat A, Deshpande AV, Podder A, Jani P.   +6 more
europepmc   +1 more source

Prevalence of Vitamin B12 Deficiency Among Diabetic Patients Taking Metformin in Jordan. [PDF]

Cureus
Ja'anini SS, Ababneh MS.
europepmc   +1 more source

A Case of Bullous Pemphigoid Triggered by COVID-19 Infection in a Patient Receiving a Dipeptidyl Peptidase-4 Inhibitor. [PDF]

Cureus
Fukata M, Omura T, Maeda K, Mori T, Kato H, Kuzuya M.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Vildagliptin

Drugs, 2006
Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that is being evaluated in the treatment of patients with type 2 diabetes mellitus. It improves glycaemic control by inhibiting DPP-4 from inactivating the incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide, prolonging incretin activity in response to ...
Sheridan, Henness, Susan J, Keam
  +6 more sources

Vildagliptin

Reactions Weekly, 2023
  +6 more sources